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Abstract
Background: The level of intra-species genetic variation in Entamoeba histolytica, Entamoeba dispar
and Entamoeba moshkovskii populations in a localized geographic area, like Puducherry, India,
remains unknown.
Methods:  In the present study the existence of genetic variation in the nested multiplex
polymerase chain reaction (NM-PCR) amplified region of the 16S-like ribosomal RNA genes of E.
histolytica, E. dispar and  E. moshkovskii was investigated by riboprinting and single strand
conformation polymorphism (SSCP) analysis.
Results: We found that 70 stool specimens were positive for E. histolytica, 171 stool specimens
were positive for E. dispar, and 37 stool specimens were positive for E. moshkovskii by NM-PCR.
Ninety liver abscess pus specimens, 21 urine specimens, and 8 saliva specimens were positive for
E. histolytica by NM-PCR. Riboprinting analysis detected a mutation in the PCR product of only one
E. histolytica isolate from a stool specimen. However, SSCP analysis detected mutations in the PCR
products of five E. histolytica isolates and three E. moshkovskii isolates from stool specimens, and one
E. histolytica isolate from a saliva specimen. The mutations detected by riboprinting and SSCP
analysis were confirmed by sequencing. All the nucleotide sequences showing mutations in this
study have already been deposited into the NCBI GenBank database under accession numbers
[GenBank: EF682200 to GenBank: EF682208].
Conclusion: The present study has revealed the subsistence of mutations in the ribosomal RNA
genes of E. histolytica and E. moshkovskii, which points towards the existence of intra-species genetic
variation in E. histolytica and E. moshkovskii isolates infecting humans.
Background
The protozoan parasite Entamoeba histolytica is estimated
to infect 50 million people and cause 40,000 to 100,000
deaths annually, making it the second largest cause of
mortality from infection with parasitic protozoa after
malaria [1].
Although the first description of amoebiasis was more
than a century ago [2], there is still uncertainty as to why
symptoms of the disease appear only in 10% of those
infected with E. histolytica while majority remains asymp-
tomatic [3]. There have been several suggestions regarding
the factors that may contribute to the outcome of amoebic
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infection in a susceptible host, which include a range of
virulence levels among the E. histolytica strains and varia-
bility in host immunity against amoebic invasion. While
the variability of human immunity against amoebic infec-
tion is not well understood, the existence of genetic varia-
tion in E. histolytica has been studied in depth recently [4-
17]. These studies have identified genetic variation in pro-
tein-coding sequences of E. histolytica, such as those for
the serine-rich E. histolytica protein [10-15] and chitinase
[8,11,12], as well as non-protein-coding regions such as
the ribosomal RNA (rRNA) genes [4,5,7] and loci 1–2 and
5–6 [11,12,16,17]. In addition, the existence of genetic
variation in non-protein-coding loci 1–2 and 5–6 [18], as
well as protein-coding chitinase gene of E. dispar has been
reported recently [19].
These genetic variation studies appear to be promising in
investigating the molecular epidemiology of amoebiasis.
The existence of significant genetic variation among E. his-
tolytica isolates collected from a wide geographical range,
including Mexico, Bangladesh, India, Venezuela, South
Africa, the Philippines, and Georgia, has already been
demonstrated [8,9,13,14]. However, whether intra-spe-
cies genetic variation also exists in E. histolytica, Entamoeba
dispar and Entamoeba moshkovskii from a population in a
restricted geographic area like Puducherry, India, still
remains unknown.
The rRNAs, especially the 16S rRNA, have been widely
used for studying genetic variation because of their con-
servative nature and universal distribution [20]. In the
present study an attempt has been made to study genetic
variation in regions of the 16S-like rRNA gene of E. histo-
lytica, E. dispar and E. moshkovskii using riboprinting and
single strand conformation polymorphism (SSCP) analy-
sis followed by confirmation by nucleotide sequencing.
Methods
Sample details
The study was conducted at the Jawaharlal Institute of
Postgraduate Medical Education and Research (JIPMER)
hospital, Puducherry, India, during the period from July
2004 to July 2006. Informed consent was obtained from
the patients. The study was approved by the Institute
Human Ethics Committee (JIPMER, Puducherry, India).
Stool
Fresh unpreserved stool samples from 202 patients with
complaints of gastrointestinal discomfort and positive for
E. histolytica, E. dispar, or E. moshkovskii by microscopy or
culture were collected in sterile capped containers and
stored at -20°C until used.
Liver abscess pus
The liver abscess pus aspiration was performed only for
clinical purposes, as judged necessary by the clinicians for
the patient care and not for the purpose of this study. The
liver abscess pus was obtained under ultrasound guidance
from 112 amoebic liver abscess (ALA) patients and stored
at -20°C in a sterile container until used.
Urine
A urine specimen was collected from 53 ALA patients. Ten
millilitres of urine were collected in a sterile container
using aseptic techniques and stored at -20°C until used.
Saliva
A saliva specimen was collected from 28 ALA patients.
Five millilitres of saliva were collected in a sterile con-
tainer using aseptic techniques and stored at 4°C until
used.
Entamoeba 16S-like rRNA gene amplification by nested 
multiplex polymerase chain reaction (NM-PCR)
Extraction of Entamoeba genomic DNA
The extraction of Entamoeba genomic DNA from stool,
liver abscess pus, urine, and saliva specimens was per-
formed as per the method described previously [21-23].
Primers used
Based on the sequences of the 16S-like rRNA gene of E.
histolytica, E. dispar and E. moshkovskii, nested sets of prim-
ers (designated E-1/E-2, EH-1/EH-2, ED-1/ED-2 and Mos-
1/Mos-2) were used as described previously [21].
Standard strains
E. histolytica HM-1:IMSS, E. dispar SAW760, and E. moshk-
ovskii Laredo were the standard strains used as positive
controls in the present study. The lyophilized DNA of
these strains was generously gifted by Dr. C. Graham
Clark from the London School of Hygiene and Tropical
Medicine, London, UK.
NM-PCR
Stool PCR
The PCR mix composition was as described previously
[21].
Liver abscess pus PCR
For genus specific and species specific PCR, the reaction
volume of 25 μl was comprised of 2.5 μl of 10× PCR
buffer (Biogene), 2.0 μl of 25 mM MgCl2 (Bangalore
genei), 0.75 μl of deoxyribo-nucleotide triphosphate mix
(10 mM each dNTP, Biogene), 0.3 μl (5 IU/μl) of Taq
polymerase (Biogene), 0.25 μM primers (IDT) and 2.0 μl
of template DNA. Amplification was performed in an
Eppendorf Thermal cycler [Master cycler gradient].
Urine PCR
The PCR mix composition was the same as described
above for liver abscess pus PCR, except that 1.0 μl of 25
mM MgCl2 and 2.5 μl of template DNA was added.BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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Saliva PCR
The PCR mix composition was the same as described
above for liver abscess pus PCR, except that 1.0 μl of 25
mM MgCl2 was added.
The PCR cycle conditions were as described previously
[21].
Mutation detection by riboprinting
Restriction enzymes
Restriction enzymes were used to generate comparative
riboprints. The restriction enzymes were selected for the
439 bp, 553 bp and 174 bp PCR product of 16S-like rRNA
gene of E. histolytica, E. moshkovskii and E. dispar, respec-
tively, using the online software "NEB cutter V2.0" http://
tools.neb.com/NEBcutter2/index.php. The restriction
enzymes used are shown in Table 1.
Restriction enzyme digestion
In a 25 μl reaction mix, 15 μl of nested PCR product was
digested with 2.5 units of each restriction enzyme in sep-
arate 0.2 ml tubes. The incubation period was for 16 hrs
at 37°C except for the restriction enzymes Taq I and Mse I
where the incubation temperature was 65°C.
Agarose gel electrophoresis
Twenty microlitres of the restriction enzyme digested PCR
product was separated by electrophoresis through a 2.5%
agarose gel (Agarose Low EEO, Bangalore genie products,
Bangalore, India) containing ethidium bromide in 0.5 ×
Tris-acetate-EDTA (TAE) buffer at 120 V for 45 min and
was visualized under UV light.
Mutation detection by SSCP
Preparation of the SSCP gel
In the present study 6% and 9% SSCP gels were used. Six
percent SSCP gels were used for mutation detection in the
439 bp and 553 bp PCR products of E. histolytica and E.
moshkovskii, respectively. A nine percent SSCP gel was used
for mutation detection in the 174 bp PCR product of E.
dispar.
Preparation of samples for SSCP electrophoresis
Two microlitres of the nested PCR product was diluted
into 20 μl formamide dye mix in a 0.2 ml microfuge tube.
A similar aliquot was diluted into 20 μl of gel loading dye.
The formamide containing sample was boiled for 6 min-
utes in a water bath, and then the tube was plunged
directly into ice for 10 minutes.
Separation of DNA fragments by SSCP gel electrophoresis
The wells of the polyacrylamide gel were washed with 1×
TAE electrophoresis buffer. 4 μl of denatured DNA (DNA
boiled with formamide dye mix) was loaded into the well
of polyacrylamide gel. Two microlitres of non-denatured
DNA (DNA with gel loading dye) was loaded into another
well. Approximately 6–7 V/cm (~110 V [and 16 mA] for
18 × 14-cm gel) was applied to the gel for 16 hrs at a tem-
perature of 20–25°C in an air conditioned room. On
completion of the electrophoresis, the gel was silver
stained.
Silver staining of SSCP gel
Silver staining for nucleic acid was performed as per the
method described previously [20]. The gel was docu-
mented using a densitometer (Biorad) and the results ana-
lyzed using "Quantity One" software (Biorad). For long
term storage the gel was kept in 10% glycerol.
Nucleotide sequencing
PCR products of 16S-like rRNA genes of E. histolytica, E.
dispar and E. moshkovskii showing mutation by riboprint-
ing or SSCP analysis, were sequenced on a ABI3730XL
sequencer (Macrogen, Seoul, South Korea) using species
specific primers. The nucleotide sequences were edited
with reference to chromatographs using Chromas (Ver-
sion 1.62) software and aligned using BioEdit (version 7).
Nucleotide sequence accession numbers
The nucleotide sequences showing mutations in this
study have been deposited into the NCBI GenBank data-
base under accession numbers EF682200–EF682208]
(Table 2).
Results
Entamoeba 16S-like r RNA gene amplification by NM-
PCR
Stool PCR
Seventy stool specimens were positive for the 439 bp PCR
product of E. histolytica, 171 stool specimens were positive
for the 174 bp PCR product of E. dispar, and 37 stool spec-
imens were positive for the 553 bp PCR product of E.
moshkovskii.
Liver abscess pus PCR
Ninety liver abscess pus specimens were positive for the
439 bp PCR product of E. histolytica.
Table 1: Restriction enzymes used for riboprinting analysis of 
partial regions of the 16S-like rRNA genes of E. histolytica, E. 
dispar and E. moshkovskii
E. histolytica (439 bp) E. moshkovskii (553 bp) E. dispar (174 bp)
Xba I Taq I Taq I
Dde I Dde I Dde I
Hpy188 III Hpy188 III Mse I
Mfe I Mfe I Sau96 I
N1aIV N1aIV
Hinf I Hinf I
Mse I Mse I
Sau96 IBMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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Urine PCR
Twenty one urine specimens were positive for the 439 bp
PCR product of E. histolytica.
Saliva PCR
Eight saliva specimens were positive for the 439 bp PCR
product of E. histolytica.
Mutation detection by riboprinting
No intra-species variation in restriction fragment length
polymorphism (RFLP) patterns for any restriction enzyme
was observed, except for the N1aIV RFLP pattern of the E.
histolytica specific 439 bp PCR product from one stool
specimen (Stool- 5).
Normal RFLP digestion pattern for the 174 bp, 439 bp,
and 553 bp PCR product of E. dispar, E. histolytica and E.
moshkovskii respectively with various restriction enzymes
are shown in figure 1.
Mutation detection by SSCP
Five out of 70 E. histolytica specific 439 bp PCR products
from stool specimens, one out of 8 E. histolytica specific
439 bp PCR products from saliva specimens, and three
out of 37 E. moshkovskii specific 553 bp PCR products
from stool specimens showed an altered SSCP profile (i.e.
a mobility shift in the acrylamide gel) suggestive of a
mutation (Figure 2 and Figure 3).
None of the 171 E. dispar specific 174 bp PCR products
from stool specimens, 90 E. histolytica specific 439 bp PCR
products from liver abscess pus specimens, or 21 E. histo-
lytica specific 439 bp PCR products from urine specimens
showed an altered SSCP profile suggestive of a mutation.
The E. histolytica and E. moshkovskii isolates showing muta-
tions by PCR-SSCP analysis are summarized in table 2.
Nucleotide sequencing
All four E. histolytica specific 439 bp PCR products from
stool specimens (Stool- 1, 2, 3, and 4) showing a muta-
tion by SSCP analysis and the E. histolytica specific 439 bp
PCR product from stool specimen showing mutation by
both SSCP and riboprinting analysis (Stool- 5), were con-
firmed by nucleotide sequencing. The multiple sequence
alignment of these sequencing results and the standard
strain E. histolytica HM-1:IMSS is depicted in figure 4. The
comparative electropherogram showing the mutant
(Stool- 1, 2, 3, 4, and 5) and normal control (E. histolytica
HM-1:IMSS) 16S-like rRNA genes is shown in figure 5.
All three E. moshkovskii PCR products showing mutation
by SSCP analysis (Stool- 6, 7, and 8) were confirmed by
nucleotide sequencing. The multiple sequence alignment
of these sequences and the standard strain E. moshkovskii
Laredo is depicted in figure 6. The comparative electroph-
erogram showing the mutant (Stool- 6, 7, and 8) and nor-
mal control (E. moshkovskii Laredo) 16S-like rRNA genes is
shown in figure 7.
The one E. histolytica PCR product from a saliva specimen
showing mutation by SSCP analysis was also confirmed
by sequencing. The multiple sequence alignment of the
results from this saliva specimen and the standard strain
E. histolytica HM-1:IMSS is depicted in figure 4. The com-
parative electropherogram showing the mutant (Saliva-1)
Table 2: E. histolytica and E. moshkovskii isolates obtained from clinical specimens of patients attending JIPMER hospital, Puducherry, 
showing mutation by PCR-SSCP analysis
S. No Entamoeba species Clinical specimen GenBank submission [GenBank accession number]
1 E. histolytica Stool Entamoeba histolytica isolate 1 [GenBank: EF682200]
2 E. histolytica Stool Entamoeba histolytica isolate 2 [GenBank: EF682201]
3 E. histolytica Stool Entamoeba histolytica isolate 3 [GenBank: EF682202]
4 E. histolytica Stool Entamoeba histolytica isolate 4 [GenBank: EF682203]
5 E. histolytica Stool Entamoeba histolytica isolate 5 [GenBank: EF682204]
6 E. moshkovskii Stool Entamoeba moshkovskii isolate 6 [GenBank: EF682206]
7 E. moshkovskii Stool Entamoeba moshkovskii isolate 7 [GenBank: EF682207]
8 E. moshkovskii Stool Entamoeba moshkovskii isolate 8 [GenBank: EF682208]
9 E. histolytica Saliva Entamoeba histolytica isolate 1 [GenBank: EF682205]
Normal RFLP digestion pattern for 174 bp, 439 bp, and 553  bp PCR products of E. dispar, E. histolytica and E. moshkovskii  respectively with various restriction enzymes Figure 1
Normal RFLP digestion pattern for 174 bp, 439 bp, 
and 553 bp PCR products of E. dispar, E. histolytica 
and E. moshkovskii respectively with various restric-
tion enzymes. Lane-1 to 4 normal riboprints for E. dispar 
(ED); Lane-5 to 11 normal riboprints for E. histolytica (EH); 
Lane-12 to 19 normal riboprints for E. moshkovskii (EM).BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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and normal control (E. histolytica HM-1:IMSS) is shown in
figure 8.
Discussion
Mutations and other polymorphisms in genes, gene sys-
tems, or whole genomes may play an important role in
Entamobea. DNA sequencing is considered the gold stand-
ard for identifying such mutations. Nevertheless, DNA
sequencing method is cumbersome and costly when large
numbers of samples need to be rapidly analyzed. The
method, therefore, is not always suitable for use in epide-
miological studies.
In the present study, PCR products of 16S-like rRNA gene
of E. histolytica, E. moshkovskii and E. dispar were subjected
to screening for mutation by riboprinting and SSCP anal-
ysis. These products were of a relatively small sizes, 553 bp
for E. moshkovskii, 439 bp for E. histolytica and 174 bp for
E. dispar, and were found to be particularly suitable for
SSCP analysis.
Riboprinting analysis detected a mutation in only one of
the E. histolytica samples, from a stool specimen (Stool-
5); the alteration in the RFLP pattern (i.e. the PCR product
remained undigested) was due to substitution of G by A
in the recognition site of N1aIV. The inability of riboprint-
ing to detect mutations in a majority of Entamoeba isolates
is due to the limitation that RFLP detects mutation only
when they occur in restriction endonuclease cut sites.
SSCP analysis showing altered profile (mobility shift) for the  439 bp PCR product of E. histolytica. Lane-1 is for E. histolytica  standard DNA (EH-Std) Figure 2
SSCP analysis showing altered profile (mobility shift) 
for the 439 bp PCR product of E. histolytica. Lane-1 is 
for E. histolytica standard DNA (EH-Std); Lane-2, 3, 4, 5, and 6 
are for E. histolytica DNA from stool specimens showing an 
altered profile; Lane-7 is for E. histolytica DNA from a saliva 
specimen showing an altered profile.
SSCP analysis showing altered profile (mobility shift) for the  553 bp PCR product of E. moshkovskii. Lane-1 is for E. moshk- ovskii standard DNA (EM-Std) Figure 3
SSCP analysis showing altered profile (mobility shift) 
for the 553 bp PCR product of E. moshkovskii. Lane-1 
is for E. moshkovskii standard DNA (EM-Std); Lane-2, 
3, and 4 are for E. moshkovskii DNA from stool specimens 
showing an altered profile.BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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Multiple sequence alignment of E. histolytica specific 439 bp PCR products from clinical specimens (Stool-1 to 5 and Saliva-1)  and the standard strain E. histolytica HM-1:IMSS (EH-Std) Figure 4
Multiple sequence alignment of E. histolytica specific 439 bp PCR products from clinical specimens (Stool-1 to 5 
and Saliva-1) and the standard strain E. histolytica HM-1:IMSS (EH-Std). The sequence variations are highlighted in 
red.BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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However, SSCP analysis detected mutation in a total of
five E. histolytica and three E. moshkovskii isolates from
stool and one E. histolytica isolate from saliva. This may be
attributed to the ability of SSCP, unlike RFLP, to detect
any mutation in a DNA sequence. The SSCP analysis
results that were suggestive of mutations were reproduci-
ble (i.e. SSCP analysis showed identical profiles in three
separate experiments).
In this study none of the 171 E. dispar isolates showed
characteristics suggestive of mutation by SSCP analysis,
perhaps due to the screening of only a 174 bp region of
the gene. The chances of finding a mutation in such a
small region is less than in larger regions studied for the
other two species.
Although it was observed that riboprinting was useful for
screening a large number of samples, especially when
looking for a specific single nucleotide polymorphism,
the method has some inherent disadvantages. In this
method, a large amount of amplicon (15 μl) is needed for
digestion with each of several enzymes, and each clinical
sample ends up being electrophoresed on several gels,
making it a very laborious and time consuming proce-
dure.
SSCP analysis, on the other hand, was found to be simple
and convenient in the present study. The results were
obtained from only 2 μl of PCR product on a single SSCP
gel, which in the long run turned out to be much more
economical. The total time needed for PCR-SSCP was less
than 24 hours. The SSCP technique developed and evalu-
ated in our laboratory provides us with a rapid tool for
detecting mutations in Entamoeba. This method could
conveniently supplement other methods of mutation
detection analysis on large-scale. The limitation of SSCP,
although minor, is that it detects the occurrence of single
base mutations in a segment of DNA but does not give any
information on the type or location of the base changes,
which have to be confirmed by nucleotide sequencing.
In the present study, the results showed that SSCP analysis
was able to detect even single nucleotide differences (Fig-
ure 5, Figure 7, and Figure 8). Nucleotide sequences were
verified three times by sequencing of products of different
PCR reaction from the same source of DNA to rule out any
discrepancy due to sequencing errors. The sequencing
analysis identified four new E. histolytica genotypes and
three new E. moshkovskii genotypes (Figure 4 and Figure
6). Recently, a report from Bangladesh [16] studied clini-
cal specimens using six tRNA-linked STR loci, and
detected 85 genotypes in 111 unrelated samples. Another
report from Bangladesh [15] also studied clinical samples
but used a nested PCR-RFLP of the SREHP gene. Twenty
five genotypes among 42 intestinal isolates and 9 geno-
types among 12 ALA samples were found. Out of 9 geno-
types from liver abscess samples, 8 were unique to the ALA
samples investigated. In our study no unique genotypes
among any of the liver abscess samples and urine samples
from ALA cases were found, but out of 5 E. histolytica gen-
otypes from stool samples 4 were unique to the stool sam-
ples investigated. In addition, our study also detected one
unique E. histolytica genotype from a saliva sample from
an ALA case and three new E. moshkovskii genotypes from
stool samples. Clark and Diamond [6] combined results
of both PCR-RFLP of SREHP and amplification of the SSG
locus to report 16 different genotypes among 18 isolates
of  E. histolytica from varied geographical locations.
Haghighi et al. [11] reported a total of 53 different geno-
types among 63 isolates of E. histolytica, mostly from
Japan and Thailand, using sequencing of four loci (two
tRNA-linked STR loci, chitinase, and SREHP). The high
level of diversity reported from different geographic loca-
tions suggest that the rapid generation of new Entamoeba
Electropherogram showing the mutant (Stool-1 to 5) and  normal control E. histolytica HM-1:IMSS (EH-Std) 16S-like  rRNA genes Figure 5
Electropherogram showing the mutant (Stool-1 to 5) 
and normal control E. histolytica HM-1:IMSS (EH-
Std) 16S-like rRNA genes. Chromatogram showing the 
sequence variation is indicated by an arrow. The sequencing 
revealed substitution of A by G and substitution of A by T 
(A), insertion of T (B), insertion of T (C), insertion of T (D), 
and substitution of G by A and insertion of T (E).BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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Multiple sequence alignment of the E. moshkovskii specific 553 bp PCR products from stool specimens (Stool-6 to 8) and the  standard strain E. moshkovskii Laredo (EM-Std) Figure 6
Multiple sequence alignment of the E. moshkovskii specific 553 bp PCR products from stool specimens (Stool-6 
to 8) and the standard strain E. moshkovskii Laredo (EM-Std). The sequence variations are highlighted in red.BMC Infectious Diseases 2008, 8:131 http://www.biomedcentral.com/1471-2334/8/131
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variants is taking place. The occurrence of new E. histolyt-
ica and E. moshkovskii genotypes in the area of Puducherry,
India, may be a unique finding and the close relationship
of these genotypes with a recognized human pathogen
like  E. histolytica should prompt further studies.
In this study, the presence of mutations was explored in a
region of 16S-like rRNA gene of E. histolytica, E. dispar and
E. moshkovskii by applying riboprinting and SSCP analysis.
Further studies are needed to extend mutation detection
to the complete ribosomal RNA gene of these species,
which will possibly reveal much more about genetic vari-
ation in Entamoeba.
Conclusion
The present study has revealed the subsistence of muta-
tion in ribosomal RNA gene of E. histolytica and E. moshk-
ovskii, which points towards the existence of intra-species
genetic variation in E. histolytica and E. moshkovskii isolates
infecting humans.
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